A Phase II Study of RAD001 (Everolimus) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 04 Dec 2012 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 25 May 2010 New source identified and integrated (Memorial Sloan-Kettering Cancer Center ).
- 01 Jul 2009 Planned number of patients changed from 46 to 23 as reported by ClinicalTrials.gov.